• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种具有挑战性的 α-1-抗胰蛋白酶缺乏症诊断:鉴定出一位具有新型 F/Null 表型的患者。

A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.

机构信息

Department of Medicine, Section of Allergy and Immunology, The Pennsylvania State University Milton S, Hershey Medical Center, 500 University Dr,, Hershey, PA 17033, USA.

出版信息

Allergy Asthma Clin Immunol. 2011 Nov 13;7(1):18. doi: 10.1186/1710-1492-7-18.

DOI:10.1186/1710-1492-7-18
PMID:22078084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3229436/
Abstract

Alpha-1-antitrypsin (A1AT) deficiency is a genetic disease characterized by low levels and/or function of A1AT protein. A1AT deficiency can result in the development of COPD, liver disease, and certain skin conditions. The disease can be diagnosed by demonstrating a low level of A1AT protein and genotype screening for S and Z mutations, which are the most common. However, there are many genetic variants in A1AT deficiency, and this screening may miss rarer cases, such as those caused by dysfunctional protein. We identified a patient with a previously unreported F/null phenotype that was missed by routine screening. This case highlights the wide variation in possible mutations, limitations in diagnostics, and the importance of combining clinical suspicion with measurement of protein levels, phenotypic analysis, and in appropriate cases expanded genetic analysis.

摘要

α-1-抗胰蛋白酶(A1AT)缺乏症是一种遗传性疾病,其特征为 A1AT 蛋白水平低和/或功能丧失。A1AT 缺乏症可导致 COPD、肝脏疾病和某些皮肤状况的发生。该疾病可通过检测 A1AT 蛋白水平降低和 S 和 Z 突变的基因型筛查来诊断,这些突变是最常见的。然而,A1AT 缺乏症存在许多遗传变异,这种筛查可能会遗漏更罕见的病例,如由功能失调的蛋白引起的病例。我们鉴定了一例以前未报道的 F/null 表型患者,该患者被常规筛查漏诊。该病例突出了可能的突变存在广泛的变异,诊断存在局限性,以及将临床怀疑与蛋白水平测量、表型分析相结合并在适当情况下进行扩展基因分析的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c719/3229436/9b9401fa0fec/1710-1492-7-18-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c719/3229436/9b9401fa0fec/1710-1492-7-18-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c719/3229436/9b9401fa0fec/1710-1492-7-18-1.jpg

相似文献

1
A challenging diagnosis of alpha-1-antitrypsin deficiency: identification of a patient with a novel F/Null phenotype.一种具有挑战性的 α-1-抗胰蛋白酶缺乏症诊断:鉴定出一位具有新型 F/Null 表型的患者。
Allergy Asthma Clin Immunol. 2011 Nov 13;7(1):18. doi: 10.1186/1710-1492-7-18.
2
α-1 Antitrypsin Genotype-Phenotype Discrepancy in a 42-Year-Old Man Who Carries the Null-Allele.一名携带无效等位基因的42岁男性的α-1抗胰蛋白酶基因型-表型差异
Lab Med. 2020 May 6;51(3):301-305. doi: 10.1093/labmed/lmz059.
3
Null: A novel α-antitrypsin allele with in cis variants Glu366Lys and Ile100Asn.Null:一种新型α-1 抗胰蛋白酶等位基因,具有顺式变异 Glu366Lys 和 Ile100Asn。
Clin Biochem. 2020 May;79:23-27. doi: 10.1016/j.clinbiochem.2020.02.013. Epub 2020 Feb 19.
4
[Place of genotyping in addition to the phenotype and the assay of serum α-1 antitrypsin].除了对血清α-1抗胰蛋白酶进行表型分析和检测外,还需进行基因分型的地点
Ann Biol Clin (Paris). 2011 Sep-Oct;69(5):571-6. doi: 10.1684/abc.2011.0613.
5
Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.α1-抗胰蛋白酶缺乏症的连锁分析:复杂疾病的经验教训
Hum Hered. 2001;52(4):223-32. doi: 10.1159/000053380.
6
Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping.α-1抗胰蛋白酶缺乏症的诊断:定量、基因分型和表型分析算法
Clin Chem. 2006 Dec;52(12):2236-42. doi: 10.1373/clinchem.2006.072991. Epub 2006 Oct 19.
7
Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.α-1抗胰蛋白酶替代疗法治疗α-1抗胰蛋白酶缺乏症患者的安全性和有效性。
Biologics. 2009;3:193-204. doi: 10.2147/btt.2009.3088. Epub 2009 Jul 13.
8
[Development of a laboratory test on dried blood spots for facilitating early diagnosis of alpha-1-antitrypsin deficiency].[用于促进α-1-抗胰蛋白酶缺乏症早期诊断的干血斑实验室检测方法的开发]
Ann Biol Clin (Paris). 2014 Nov-Dec;72(6):689-704. doi: 10.1684/abc.2014.1004.
9
Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.α-1抗胰蛋白酶缺乏症:一种与肺部和肝脏表现相关的构象性疾病。
J Inherit Metab Dis. 2008 Feb;31(1):21-34. doi: 10.1007/s10545-007-0748-y. Epub 2008 Jan 16.
10
Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.成人和儿科人群α(1)-抗胰蛋白酶表型定量的参考和解释范围。
Am J Clin Pathol. 2012 Sep;138(3):398-405. doi: 10.1309/AJCPMEEJK32ACYFP.

引用本文的文献

1
Alpha-1-Antitrypsin (A1AT) Proteotyping by LC-MS/MS.基于 LC-MS/MS 的α-1-抗胰蛋白酶(A1AT)蛋白谱分析。
Methods Mol Biol. 2024;2750:95-106. doi: 10.1007/978-1-0716-3605-3_9.
2
Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants.通过大型α-1抗胰蛋白酶缺乏症筛查项目鉴定的新型SERPINA1等位基因及已知变异的综述。
Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):7-21. doi: 10.15326/jcopdf.2022.0321.
3
The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency.

本文引用的文献

1
Clinical practice. Alpha1-antitrypsin deficiency.临床实践。α1-抗胰蛋白酶缺乏症。
N Engl J Med. 2009 Jun 25;360(26):2749-57. doi: 10.1056/NEJMcp0900449.
2
Alpha-1-antitrypsin deficiency panniculitis.α-1抗胰蛋白酶缺乏性脂膜炎
Dermatol Clin. 2008 Oct;26(4):447-51, vi. doi: 10.1016/j.det.2008.05.001.
3
Alpha-1 antitrypsin Null mutations and severity of emphysema.α-1抗胰蛋白酶基因无效突变与肺气肿严重程度
需要进行持续质量评估,为α-1 抗胰蛋白酶缺乏症患者提供最佳的综合护理。
Allergy Asthma Proc. 2021 Nov 1;42(6):537-542. doi: 10.2500/aap.2021.42.210067.
4
Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center.在美国一个中心发现的4例罕见α1抗胰蛋白酶变体患者的临床表现。
Respir Med Case Rep. 2021 Jan 20;32:101345. doi: 10.1016/j.rmcr.2021.101345. eCollection 2021.
5
Leveraging Population Genomics for Individualized Correction of the Hallmarks of Alpha-1 Antitrypsin Deficiency.利用群体基因组学对α-1抗胰蛋白酶缺乏症的特征进行个体化校正。
Chronic Obstr Pulm Dis. 2020 Jul;7(3):224-246. doi: 10.15326/jcopdf.7.3.2019.0167.
6
Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.利用蛋白质建模技术评估疑似患有α1-抗胰蛋白酶缺乏症患者的 SERPINA1 罕见变异体的致病性。
BMC Med Genet. 2019 Jul 15;20(1):125. doi: 10.1186/s12881-019-0852-5.
7
The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote.α-1-抗胰蛋白酶 F 变体的意义及 PiFF 纯合子的独特病例报告。
BMC Pulm Med. 2014 Aug 7;14:132. doi: 10.1186/1471-2466-14-132.
Respir Med. 2008 Jun;102(6):876-84. doi: 10.1016/j.rmed.2008.01.009. Epub 2008 Mar 18.
4
Diagnosis of alpha-1-antitrypsin deficiency: An algorithm of quantification, genotyping, and phenotyping.α-1抗胰蛋白酶缺乏症的诊断:定量、基因分型和表型分析算法
Clin Chem. 2006 Dec;52(12):2236-42. doi: 10.1373/clinchem.2006.072991. Epub 2006 Oct 19.
5
Alpha-1-antitrypsin associated panniculitis: the MS variant.α-1-抗胰蛋白酶相关脂膜炎:MS 变异型
J Am Acad Dermatol. 2004 Oct;51(4):645-55. doi: 10.1016/j.jaad.2003.12.053.
6
American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.美国胸科学会/欧洲呼吸学会声明:α-1抗胰蛋白酶缺乏症个体的诊断和管理标准
Am J Respir Crit Care Med. 2003 Oct 1;168(7):818-900. doi: 10.1164/rccm.168.7.818.
7
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.α1抗胰蛋白酶缺乏症的全球种族和民族分布:已发表的遗传流行病学调查分析总结
Chest. 2002 Nov;122(5):1818-29. doi: 10.1378/chest.122.5.1818.
8
Kinetic characterisation of alpha-1-antitrypsin F as an inhibitor of human neutrophil elastase.α-1-抗胰蛋白酶F作为人中性粒细胞弹性蛋白酶抑制剂的动力学特性研究
Pathology. 1996 Aug;28(3):242-7. doi: 10.1080/00313029600169074.
9
Is the PiF allele of alpha 1-antitrypsin associated with pulmonary disease?α1抗胰蛋白酶的蛋白酶抑制因子(PiF)等位基因与肺部疾病有关吗?
Clin Genet. 1984 Jun;25(6):491-5.
10
Deletion/frameshift mutation in the alpha 1-antitrypsin null allele, PI*QObolton.α1-抗胰蛋白酶无效等位基因PI*QObolton中的缺失/移码突变。
Hum Genet. 1989 Nov;83(4):377-82. doi: 10.1007/BF00291385.